Tenet Healthcare
About: Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Employees: 98,000
0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
58% more call options, than puts
Call options by funds: $370M | Put options by funds: $234M
1.86% more ownership
Funds ownership: 91.08% [Q3] → 92.93% (+1.86%) [Q4]
5% less funds holding
Funds holding: 598 [Q3] → 571 (-27) [Q4]
11% less repeat investments, than reductions
Existing positions increased: 198 | Existing positions reduced: 222
13% less first-time investments, than exits
New positions opened: 88 | Existing positions closed: 101
21% less capital invested
Capital invested by funds: $14.5B [Q3] → $11.5B (-$3.02B) [Q4]
42% less funds holding in top 10
Funds holding in top 10: 19 [Q3] → 11 (-8) [Q4]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$137
4%
downside
Avg. target
$175
22%
upside
High target
$230
61%
upside
7 analyst ratings
6 positive
86%
1 neutral
14%
0 negative
0%
RBC Capital Ben Hendrix 35% 1-year accuracy 25 / 71 met price target | 32%upside $189 | Outperform Maintained | 30 Apr 2025 |
UBS A.J. Rice 42% 1-year accuracy 8 / 19 met price target | 61%upside $230 | Buy Maintained | 30 Apr 2025 |
Baird Michael Ha 39% 1-year accuracy 9 / 23 met price target | 4%downside $137 | Neutral Downgraded | 15 Apr 2025 |
Guggenheim Jason Cassorla 14% 1-year accuracy 2 / 14 met price target | 15%upside $165 | Buy Initiated | 9 Apr 2025 |
Morgan Stanley Craig Hettenbach 14% 1-year accuracy 1 / 7 met price target | 15%upside $165 | Overweight Initiated | 26 Mar 2025 |
Financial journalist opinion
Based on 29 articles about THC published over the past 30 days
Positive
Zacks Investment Research
4 hours ago
Tenet Beats Q1 Earnings on Strong Ambulatory Unit, Ups '25 EPS View
THC's first-quarter results benefit on the back of higher net revenue per case and the expansion of service lines within the Ambulatory Care unit. It currently expects 2025 adjusted EPS within $11.99-$13.12.
Positive
Zacks Investment Research
7 hours ago
Why Tenet Healthcare (THC) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Neutral
Seeking Alpha
1 day ago
Tenet Healthcare Corporation (THC) Q1 2025 Earnings Call Transcript
Tenet Healthcare Corporation (NYSE:THC ) Q1 2025 Earnings Conference Call April 29, 2025 10:00 AM ET Company Participants William McDowell - Vice President-Investor Relations Saum Sutaria - Chairman and Chief Executive Officer Sun Park - Executive Vice President and Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Craig Hettenbach - Morgan Stanley Investment Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Megan Holt - Jefferies Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Ben Hendrix - RBC Capital Markets Whit Mayo - Leerink Partners Ann Hynes - Mizuho Securities Benjamin Rossi - JPMorgan Chase A.J. Rice - UBS Andrew Mok - Barclays Josh Raskin - Nephron Research Operator Good morning and welcome to Tenet Healthcare's First Quarter 2025 Earnings Conference Call.
Neutral
Zacks Investment Research
1 day ago
Tenet (THC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Tenet (THC) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Positive
Zacks Investment Research
1 day ago
Tenet Healthcare (THC) Surpasses Q1 Earnings and Revenue Estimates
Tenet Healthcare (THC) came out with quarterly earnings of $4.36 per share, beating the Zacks Consensus Estimate of $3.11 per share. This compares to earnings of $3.22 per share a year ago.
Neutral
Business Wire
1 day ago
Tenet Reports Strong First Quarter 2025 Results
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2025. "We had an excellent start to the year driven by strong same-store revenue growth and operational discipline, resulting in earnings and cash flows well ahead of our expectations," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "We continue to expand access to high-quality specialty care as we effectively execute on our mission to de.
Positive
Zacks Investment Research
2 days ago
Doctor's Orders: 4 Hospital Stocks to Benefit From Industry Trends
The Zacks Medical-Hospital industry is likely to gain from growing demand, improving operating stability and finances. Companies like HCA, THC, UHS and CYH are poised to benefit from these trends.
Positive
Zacks Investment Research
2 days ago
Stay Ahead of the Game With Tenet (THC) Q1 Earnings: Wall Street's Insights on Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Tenet (THC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
Neutral
Zacks Investment Research
4 days ago
Tenet Healthcare (THC) Stock Drops Despite Market Gains: Important Facts to Note
In the most recent trading session, Tenet Healthcare (THC) closed at $122.10, indicating a -1.72% shift from the previous trading day.
Positive
Zacks Investment Research
5 days ago
All You Need to Know About Tenet (THC) Rating Upgrade to Buy
Tenet (THC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Charts implemented using Lightweight Charts™